名称 | 净值 | 日增长率 |
以下为热门基金 | ||
名称 | 净值 | 日增长率 |
红土创新科技创新股票(LOF) | 0.8095 | 2.86% |
华安沪港深机会灵活配置混合 | 1.0990 | 2.71% |
大摩万众创新混合A | 0.5411 | 2.64% |
大摩万众创新混合C | 0.5375 | 2.62% |
汇添富国证港股通创新药ETF发起式联接C | 0.9760 | 2.40% |
汇添富国证港股通创新药ETF发起式联接A | 0.9764 | 2.39% |
汇丰晋信龙腾混合A | 0.9435 | 2.34% |
北信瑞丰健康生活主题灵活配置 | 0.8390 | 2.32% |
鹏华沪深港新兴成长混合A | 0.9679 | 2.32% |
汇添富恒生香港上市生物科技ETF发起式联接(QDII)A | 0.9063 | 2.21% |
名称 | 净值 | 日增长率 |
银河医药混合A | 0.4589 | 1.30% |
银河医药混合C | 0.4512 | 1.30% |
银河康乐股票A | 1.838 | 0.93% |
银河康乐股票C | 1.812 | 0.89% |
银河龙头股票A | 0.5625 | 0.84% |
名称 | 万份收益 | 7日年化 |
银河银富货币B | 0.7693 | 1.77% |
银河银富货币A | 0.7038 | 1.53% |
银河钱包货币B | 0.2864 | 1.50% |
银河钱包货币A | 0.2601 | 1.41% |
银河钱包货币E | 0.2205 | 1.25% |
名称 | 日增长率 | 操作 |
易方达新兴成长混合 | -0.23% | |
鹏华中证国防指数(LOF)A | 0.63% | |
兴全有机增长混合 | -0.27% | |
名称 | 万份收益 | 操作 |
诺安聚鑫宝货币A | 0.4493 |
名称 | 成立以来收益 | 操作 |
(单位:万元)
报告期 | 收入合计 | 股票收入 | 占比 | 债券收入 | 占比 | 股利收入 | 占比 |
---|---|---|---|---|---|---|---|
2023-12-31 | -631.14 | 0.40 | -0.06% | 7.01 | -1.11% | 185.04 | -29.32% |
2023-06-30 | -238.70 | 0.40 | -0.17% | 4.31 | -1.81% | 113.42 | -47.51% |
2022-12-31 | -864.06 | 54.57 | -6.32% | 9.22 | -1.07% | 203.34 | -23.53% |
2022-06-30 | -274.84 | 48.46 | -17.63% | 5.83 | -2.12% | 124.77 | -45.40% |
2021-12-31 | 116.36 | 3985.09 | 3424.90% | 1.76 | 1.51% | 277.74 | 238.70% |
2021-06-30 | 1277.00 | 1289.03 | 100.94% | 0.95 | 0.07% | 110.11 | 8.62% |
2020-12-31 | 6174.51 | 2337.03 | 37.85% | 112.23 | 1.82% | 212.89 | 3.45% |
2020-06-30 | 730.74 | 478.59 | 65.49% | 64.04 | 8.76% | 142.56 | 19.51% |
2019-12-31 | 4478.88 | 983.24 | 21.95% | -0.82 | -0.02% | 264.25 | 5.90% |
2019-06-30 | 2275.85 | -180.79 | -7.94% | -5.03 | -0.22% | 135.31 | 5.95% |
2018-12-31 | -928.36 | 249.40 | -26.86% | 5.42 | -0.58% | 281.79 | -30.35% |
2018-06-30 | -327.04 | 349.81 | -106.96% | 5.48 | -1.68% | 170.13 | -52.02% |
2017-12-31 | 4373.45 | 2126.80 | 48.63% | -104.04 | -2.38% | 109.68 | 2.51% |
2017-06-30 | 3294.45 | 819.87 | 24.89% | -91.56 | -2.78% | 69.83 | 2.12% |
2016-12-31 | 68.86 | 188.55 | 273.80% | -- | -- | -- | -- |